HealthCor Management’s Penumbra PEN Stock Holding History

HealthCor Management’s Portfolio PEN Stock Details PEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$1.11M	Buy	+5,000	New	+$978K	1.02%	14

Other funds holding PEN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

HealthCor Management's PEN Position: Q4 2022 in Review

HealthCor Management opened a new position in Penumbra (PEN) in Q4 2022: 5,000 shares worth $1.11M. The stake represents 1.02% of the portfolio and ranks #14 among its holdings.

290 funds tracked by Wall St. Rank hold PEN as of Q4 2022.

HealthCor Management held 5,000 shares of Penumbra worth $1.11M as of Q4 2022.
Penumbra was a new HealthCor Management position in Q4 2022.
Penumbra made up 1.02% of HealthCor Management's portfolio in Q4 2022, its #14 holding.
290 funds tracked by Wall St. Rank held Penumbra as of Q4 2022.

Based on HealthCor Management's 13F filing for Q4 2022, filed 15 Feb 2023.